# EGFR_IUO 3.20 Clinical Study Protocol

> **NCT05959473** · NA · WITHDRAWN · sponsor: **Biocartis NV**

## Conditions studied

- NSCLC

## Interventions

- **DEVICE:** Idylla EGFR_IUO/3.20 Mutation Test

## Key facts

- **NCT ID:** NCT05959473
- **Lead sponsor:** Biocartis NV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09
- **Primary completion:** 2023-12-18
- **Final completion:** 2023-12-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants with FNA samples were enrolled
- **Last updated:** 2024-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959473, "EGFR_IUO 3.20 Clinical Study Protocol". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05959473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*